VALSTAR Drug Patent Profile
✉ Email this page to a colleague
When do Valstar patents expire, and what generic alternatives are available?
Valstar is a drug marketed by Endo Operations and is included in one NDA.
The generic ingredient in VALSTAR is valrubicin. There are two drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the valrubicin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Valstar
A generic version of VALSTAR was approved as valrubicin by HIKMA on April 19th, 2019.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for VALSTAR?
- What are the global sales for VALSTAR?
- What is Average Wholesale Price for VALSTAR?
Summary for VALSTAR
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Drug Prices: | Drug price information for VALSTAR |
| What excipients (inactive ingredients) are in VALSTAR? | VALSTAR excipients list |
| DailyMed Link: | VALSTAR at DailyMed |
US Patents and Regulatory Information for VALSTAR
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Endo Operations | VALSTAR PRESERVATIVE FREE | valrubicin | SOLUTION;INTRAVESICAL | 020892-001 | Sep 25, 1998 | AO | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
